GFPT2 and Parkinson disease: HLA‐DQA1, GFPT2, MAPT and MIR886 were reported to show significant common differential methylation in both blood and brain and have also been previously implicated in PD pathogenesis, suggesting the potential of DMRs in peripheral blood leukocytes to be used as biomarkers in PD.